TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 35202621

Group type: EXPERIMENTAL
Intervention: Azithromycin (10 mg/kg) three times weekly for 3 months along with standard treatment
Number of subjects: 120

Group type: COMPARATOR
Intervention: Standard treatment alone
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Azithromycin group
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 120
Study: 35368935

Group type: EXPERIMENTAL
Intervention: Qili Qiangxin capsule combined with sacubitril and valsartan
Number of subjects: 108
Study: 33547263

Group type: EXPERIMENTAL
Intervention: Cycling power training (CPT, n = 8)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Resistance power training (RPT, n = 10)
Number of subjects: 20
Study: 32276613

Group type: EXPERIMENTAL
Intervention: Telephone calls
Number of subjects: 11880

Group type: EXPERIMENTAL
Intervention: SMS reminders
Number of subjects: 11880

Group type: COMPARATOR
Intervention: No intervention (Control)
Number of subjects: 11880
Study: 616670506

Group type: EXPERIMENTAL
Intervention: Telmisartan
Number of subjects: 47

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 47
Study: 34973228

Group type: EXPERIMENTAL
Intervention: Moderately hypofractionated radiotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ultrafractionation (five fractions)
Number of subjects: 0
Study: 33973141

Group type: EXPERIMENTAL
Intervention: Exergame training and exercise program (EEP)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Conventional exercise program (CEP)
Number of subjects: 19
Study: 34127003

Group type: EXPERIMENTAL
Intervention: PDE
Number of subjects: 35

Group type: COMPARATOR
Intervention: RME30
Number of subjects: 35

Group type: COMPARATOR
Intervention: RME100
Number of subjects: 35
Study: 32272260

Group type: EXPERIMENTAL
Intervention: Beetroot juice (BR) 210 mL (18.6 mmol NO3‐)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Beetroot juice (BR)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo (PL) (0.12 mmol NO3‐)
Number of subjects: 10
Study: 35977072

Group type: EXPERIMENTAL
Intervention: LY2409021 (100 mg single dose)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 32939849

Group type: EXPERIMENTAL
Intervention: Oral sildenafil therapy (administered two weeks before surgery)
Number of subjects: 30
Study: 36344940

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC) 600 mg orally twice daily for 52 weeks
Number of subjects: 119

Group type: COMPARATOR
Intervention: Placebo 600 mg orally twice daily for 52 weeks
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC)
Number of subjects: 119

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 119
Study: 33198715

Group type: EXPERIMENTAL
Intervention: Nutrition education intervention for 6 months
Number of subjects: 652

Group type: COMPARATOR
Intervention: Control group (no education)
Number of subjects: 652
Study: 34738855

Group type: EXPERIMENTAL
Intervention: Duloxetine (30 mg/day for one week, then titrated to 60 mg/day for 12 weeks)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo (one capsule daily for one week, then two capsules daily for 12 weeks)
Number of subjects: 40
Study: 33675614

Group type: EXPERIMENTAL
Intervention: Dapivirine vaginal ring (VR) for HIV prevention
Number of subjects: 96
Study: 32234329

Group type: EXPERIMENTAL
Intervention: Volixibat (5, 10 or 20 mg)
Number of subjects: 197

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 197

Group type: EXPERIMENTAL
Intervention: Volixibat (any dose)
Number of subjects: 197

Group type: EXPERIMENTAL
Intervention: Volixibat
Number of subjects: 197
Study: 36496272

Group type: EXPERIMENTAL
Intervention: Counterconditioning (pairing CS+ with pleasant pictures)
Number of subjects: 175

Group type: EXPERIMENTAL
Intervention: Exposure (repeated presentation of CS‐only trials)
Number of subjects: 175

Group type: EXPERIMENTAL
Intervention: US revaluation (pairing disgusting US with pleasant pictures)
Number of subjects: 175

Group type: COMPARATOR
Intervention: Control (filler task)
Number of subjects: 175
Study: 33784020

Group type: EXPERIMENTAL
Intervention: Botox 100 U
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: Botox 50 U
Number of subjects: 176

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 176
Study: 34423919

Group type: EXPERIMENTAL
Intervention: PF-06650833
Number of subjects: 0
Study: 32289696

Group type: EXPERIMENTAL
Intervention: cathodal tDCS (c‐tDCS) 22 sessions (20min/1000 μA)
Number of subjects: 45

Group type: COMPARATOR
Intervention: sham intervention
Number of subjects: 45
Study: 35246766

Group type: EXPERIMENTAL
Intervention: Photobiomodulation and Training Group (TGPBM)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Photobiomodulation Group (GPBM)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo Photobiomodulation and Training Group (TGPLA)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Comparison between TGPBM and TGPLA
Number of subjects: 0

Group type: COMPARATOR
Intervention: Comparison between TGPBM and GPBM
Number of subjects: 0
Study: 34028826

Group type: EXPERIMENTAL
Intervention: Probiotics (one capsule/day for 30 days)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo (one capsule/day for 30 days)
Number of subjects: 48
Study: 34450396

Group type: EXPERIMENTAL
Intervention: High level of physical activity
Number of subjects: 492

Group type: COMPARATOR
Intervention: Low-moderate level of physical activity
Number of subjects: 492
Study: 35790574

Group type: EXPERIMENTAL
Intervention: Adalimumab (HUMIRA) injection
Number of subjects: 93
Study: 33622269

Group type: EXPERIMENTAL
Intervention: Integrated multidisciplinary rehabilitation programme
Number of subjects: 190

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 190
Study: 33125390

Group type: EXPERIMENTAL
Intervention: Xpert HIV-1 Qual assay (near point-of-care EID testing)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Standard of care tests (centralized laboratory-based testing)
Number of subjects: 23
Study: 35147466

Group type: EXPERIMENTAL
Intervention: Bremelanotide
Number of subjects: 3500

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3500
Study: 33754338

Group type: EXPERIMENTAL
Intervention: Fetal scalp blood sampling for lactate measurement (FBSLM) in addition to CTG monitoring
Number of subjects: 123

Group type: COMPARATOR
Intervention: CTG without FBS
Number of subjects: 123
Study: 32102728

Group type: EXPERIMENTAL
Intervention: Actively induced medical rehabilitation (112 patients underwent rehabilitation)
Number of subjects: 431

Group type: COMPARATOR
Intervention: Routine care (15 patients underwent rehabilitation)
Number of subjects: 431

Group type: EXPERIMENTAL
Intervention: Actively induced medical rehabilitation
Number of subjects: 431

Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 431
Study: 36181044

Group type: EXPERIMENTAL
Intervention: Cervical and scapula-focused resistance exercise group (CSREG)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Trapezius massage group (TMG)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Comparison between CSREG and TMG
Number of subjects: 41
Study: 33906652

Group type: EXPERIMENTAL
Intervention: 17 °C irrigation fluid
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: 27 °C irrigation fluid
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: 37 °C irrigation fluid
Number of subjects: 108
Study: 35102782

Group type: EXPERIMENTAL
Intervention: Botulinum toxin A (BTX)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Minimal acupuncture (ACU)
Number of subjects: 54
Study: 35333618

Group type: EXPERIMENTAL
Intervention: Maybe Later Baby (MLB) alone
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Augmented intervention (MLB + consultation with health care professional)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 23
Study: 34751662

Group type: EXPERIMENTAL
Intervention: ACT-based smartphone intervention (iCanQuit)
Number of subjects: 2415

Group type: COMPARATOR
Intervention: Comparison smartphone intervention (QuitGuide)
Number of subjects: 2415
Study: 32236675

Group type: EXPERIMENTAL
Intervention: DCB angioplasty
Number of subjects: 171

Group type: COMPARATOR
Intervention: Plain old balloon angioplasty
Number of subjects: 171
Study: 33212337

Group type: EXPERIMENTAL
Intervention: Active images of models presented in active stances
Number of subjects: 122

Group type: COMPARATOR
Intervention: Posed images of models
Number of subjects: 122

Group type: COMPARATOR
Intervention: Images of scenery
Number of subjects: 122
Study: 32087422

Group type: EXPERIMENTAL
Intervention: Modified Misgav Ladach (ML) technique
Number of subjects: 822

Group type: COMPARATOR
Intervention: Dörffler (Pfannenstiel - Kerr) method
Number of subjects: 822
Study: 36399114

Group type: EXPERIMENTAL
Intervention: 60EX (exercise session 60 minutes post-meal)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: 120EX (exercise session 120 minutes post-meal)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: 60EX
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: 120EX
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 13
Study: 34134777

Group type: EXPERIMENTAL
Intervention: Avmacol® (broccoli seed and sprout extracts)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo tablets (microcrystalline cellulose, coloring, magnesium stearate)
Number of subjects: 0
Study: 34190716

Group type: EXPERIMENTAL
Intervention: Vandetanib 300 mg PO daily for 2 weeks
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 33181643

Group type: EXPERIMENTAL
Intervention: 0.75% ropivacaine
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: 0.5% ropivacaine
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: 0.2% ropivacaine
Number of subjects: 132

Group type: COMPARATOR
Intervention: 0.9% normal saline (control)
Number of subjects: 132
Study: 35081912

Group type: EXPERIMENTAL
Intervention: In-clinic group visits
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Phone-based group visits
Number of subjects: 0

Group type: COMPARATOR
Intervention: In-clinic individual visits
Number of subjects: 0
Study: 32640881

Group type: EXPERIMENTAL
Intervention: Robotic rehabilitation
Number of subjects: 224

Group type: COMPARATOR
Intervention: Conventional rehabilitation
Number of subjects: 224
Study: 35857037

Group type: EXPERIMENTAL
Intervention: Acipimox and conventional treatment
Number of subjects: 80

Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 80
Study: 34772708

Group type: EXPERIMENTAL
Intervention: Lung cancer screening using low-dose computed tomography (LDCT)
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Lung cancer screening
Number of subjects: 250
Study: 35702828

Group type: EXPERIMENTAL
Intervention: Sublingual buprenorphine/naloxone (8 mg/2 mg to 24 mg/6 mg per day; flexible take-home dosing)
Number of subjects: 272

Group type: COMPARATOR
Intervention: Oral methadone (≈60-120 mg/day; closely supervised)
Number of subjects: 272

Group type: EXPERIMENTAL
Intervention: Sublingual buprenorphine/naloxone
Number of subjects: 272

Group type: COMPARATOR
Intervention: Oral methadone
Number of subjects: 272

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 272
Study: 32349893

Group type: EXPERIMENTAL
Intervention: Açaí juice (200 mL/day for 4 weeks)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Juçara juice (200 mL/day for 4 weeks)
Number of subjects: 30
Study: 36000960

Group type: EXPERIMENTAL
Intervention: Scapular movement training (SMT)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Standardized exercises (SE)
Number of subjects: 64
Study: 34443992

Group type: EXPERIMENTAL
Intervention: Coordinative exercise (CE)
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Cardiovascular exercise (CVE)
Number of subjects: 135

Group type: COMPARATOR
Intervention: Control group (CON)
Number of subjects: 135
Study: 33108244

Group type: EXPERIMENTAL
Intervention: rhG-CSF combined with minimal-dose Dec (G-Dec group: 100 µg/m2 of rhG-CSF on days 0-5 and 5 mg/m2 of Dec on days 1-5)
Number of subjects: 204

Group type: COMPARATOR
Intervention: no intervention (non-G-Dec group)
Number of subjects: 204

Group type: EXPERIMENTAL
Intervention: rhG-CSF combined with minimal-dose Dec (G-Dec group)
Number of subjects: 204
Study: 35682461

Group type: EXPERIMENTAL
Intervention: Tongue-strengthening exercise (TSE) consisting of compressing an air‐filled bulb between the tongue and hard palate for 30 min a day, 5 days a week, for 8 weeks
Number of subjects: 102

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 102
Study: 32223010

Group type: EXPERIMENTAL
Intervention: Silver duct tape occlusion for up to 8 weeks or until warts disappear
Number of subjects: 100

Group type: COMPARATOR
Intervention: Cryotherapy every 2 to 3 weeks for a maximum of four sessions or until warts disappear
Number of subjects: 100
Study: 36241128

Group type: EXPERIMENTAL
Intervention: eRAPID
Number of subjects: 167

Group type: EXPERIMENTAL
Intervention: chemoRT-eRAPID
Number of subjects: 167
Study: 34348194

Group type: EXPERIMENTAL
Intervention: Expressive writing intervention (three 15 min essays)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 100
Study: 32591498

Group type: EXPERIMENTAL
Intervention: Six repeated ketamine infusions
Number of subjects: 54

Group type: COMPARATOR
Intervention: Single ketamine infusion
Number of subjects: 54

Group type: COMPARATOR
Intervention: Midazolam (active placebo)
Number of subjects: 54
Study: 34057603

Group type: EXPERIMENTAL
Intervention: Feed rail feeding
Number of subjects: 40

Group type: COMPARATOR
Intervention: Manual gravity feeding (control)
Number of subjects: 40
Study: 33607775

Group type: EXPERIMENTAL
Intervention: Shenfu injection combined with sodium nitroprusside
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sodium nitroprusside alone
Number of subjects: 0
Study: 35620919

Group type: EXPERIMENTAL
Intervention: α-difluoromethylornithine (DFMO) administered orally at a dosage of 500 mg/m2/day for up to 5 years.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (control group) administered orally for up to 5 years.
Number of subjects: 0
Study: 35251575

Group type: EXPERIMENTAL
Intervention: Systemic rehabilitation nursing combined with WeChat publicity and education
Number of subjects: 92

Group type: COMPARATOR
Intervention: Routine nursing (Control group)
Number of subjects: 92
Study: 32436761

Group type: EXPERIMENTAL
Intervention: Glyceryl trinitrate (GTN)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study: 34614209

Group type: EXPERIMENTAL
Intervention: Chemoendocrine therapy (CT+E)
Number of subjects: 458

Group type: COMPARATOR
Intervention: Endocrine therapy (E)
Number of subjects: 458
Study: 33601378

Group type: EXPERIMENTAL
Intervention: Emollient plus cream (EC; Dermoflan®) applied once daily for 2 months
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo applied once daily for 2 months
Number of subjects: 20
Study: 32424253

Group type: EXPERIMENTAL
Intervention: Closed-loop digital meditation intervention
Number of subjects: 0
Study: 33970101

Group type: EXPERIMENTAL
Intervention: General anesthesia for 3 hr
Number of subjects: 60

Group type: COMPARATOR
Intervention: Awake controls
Number of subjects: 60
Study: 35254407

Group type: EXPERIMENTAL
Intervention: Open-label placebo
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 33989526

Group type: EXPERIMENTAL
Intervention: Observed song patterns in 15 songbird species
Number of subjects: 15

Group type: COMPARATOR
Intervention: Null models with randomly allocated constituents
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Canaries and zebra finches reared without auditory experiences
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Observed ML patterns in more than half of the cases
Number of subjects: 15
Study: 33053609

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided seminal vesicle radiography (UGSVR) combining CT three-dimensional reconstruction (CT-TR)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Standard evaluation (control group)
Number of subjects: 32
Study: 33297720

Group type: EXPERIMENTAL
Intervention: Head Start REDI intervention (evidence-based social-emotional learning program and coordinated interactive reading program)
Number of subjects: 356

Group type: COMPARATOR
Intervention: Usual practice (control group)
Number of subjects: 356
Study: 35900474

Group type: EXPERIMENTAL
Intervention: NAVIGATE (Early Intervention Services)
Number of subjects: 404

Group type: COMPARATOR
Intervention: Community Care (CC)
Number of subjects: 404

Group type: EXPERIMENTAL
Intervention: Sporadic cannabis use
Number of subjects: 404

Group type: EXPERIMENTAL
Intervention: Consistent cannabis use
Number of subjects: 404
Study: 34398020

Group type: EXPERIMENTAL
Intervention: TaperGuard ETT
Number of subjects: 50

Group type: COMPARATOR
Intervention: Conventional ETT
Number of subjects: 50
Study: 32912445

Group type: EXPERIMENTAL
Intervention: MitraClip plus guideline-directed medical therapy (GDMT)
Number of subjects: 614

Group type: COMPARATOR
Intervention: Guideline-directed medical therapy (GDMT) alone
Number of subjects: 614

Group type: EXPERIMENTAL
Intervention: MitraClip
Number of subjects: 614
Study: 35980448

Group type: EXPERIMENTAL
Intervention: CECT-based management
Number of subjects: 106

Group type: COMPARATOR
Intervention: DL (Diagnostic Laparoscopy)
Number of subjects: 106
Study: 33881221

Group type: EXPERIMENTAL
Intervention: Body fat percentage
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Whole-body fat mass
Number of subjects: 0

Group type: COMPARATOR
Intervention: Fat-free mass
Number of subjects: 0

Group type: COMPARATOR
Intervention: Appendicular lean mass
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Body mass index (BMI)
Number of subjects: 0
Study: 32404390

Group type: EXPERIMENTAL
Intervention: Automated digital brief intervention
Number of subjects: 800
Study: 35331364

Group type: EXPERIMENTAL
Intervention: Disaster preparedness app (SiBen) for 2 weeks
Number of subjects: 80

Group type: COMPARATOR
Intervention: Home visits and conventional education
Number of subjects: 80
Study: 32819048

Group type: EXPERIMENTAL
Intervention: 0.375% ropivacaine (20 ml)
Number of subjects: 62

Group type: COMPARATOR
Intervention: 0.75% ropivacaine (10 ml)
Number of subjects: 62
Study: 36173649

Group type: EXPERIMENTAL
Intervention: Oral octreotide capsules (OOC) at 60 mg/day (with titration options to 40 or 80 mg/day)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 33663235

Group type: EXPERIMENTAL
Intervention: Empagliflozin add-on therapy
Number of subjects: 59

Group type: COMPARATOR
Intervention: Conventional glucose-lowering therapy
Number of subjects: 59
Study: 33152399

Group type: EXPERIMENTAL
Intervention: MLC tracking
Number of subjects: 17

Group type: COMPARATOR
Intervention: ITV-based treatment
Number of subjects: 17
Study: 35914418

Group type: EXPERIMENTAL
Intervention: Educational intervention (six-week preparatory training programme using flipped classroom design and simulation-based workshops)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Educational intervention
Number of subjects: 11

Group type: COMPARATOR
Intervention: Standard online and workplace training (control group)
Number of subjects: 11
Study: 34148759

Group type: EXPERIMENTAL
Intervention: Brief Behavioral Treatment for Insomnia (BBTI)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 56
Study: 32715482

Group type: EXPERIMENTAL
Intervention: Rotational axis position (RAP) at heart level (P3) during SAHC
Number of subjects: 20

Group type: COMPARATOR
Intervention: Rotational axis position (RAP) at above the head (P1) during SAHC
Number of subjects: 20
Study: 36118631

Group type: EXPERIMENTAL
Intervention: Group A (suture pattern to modify gastric accommodation)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Group B (suture pattern to reduce gastric volume)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Group C (suture pattern to interrupt gastric emptying)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Overall (all groups combined)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control (no specific control group mentioned)
Number of subjects: 48
Study: 33000285

Group type: EXPERIMENTAL
Intervention: Ultrafiltration rate (UFR)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Corrected serum calcium (cCa)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Serum phosphate (iP)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Intact parathyroid hormone (iPTH)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Alkaline phosphatase (ALP)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Interventricular septum thickness (IVST)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Left ventricular mass indices (LVMI)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Time-averaged concentration of urea (TAC-urea)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Blood pressure during hemodialysis session
Number of subjects: 68
Study: 36305694

Group type: EXPERIMENTAL
Intervention: COMBO
Number of subjects: 1111

Group type: EXPERIMENTAL
Intervention: GOAL
Number of subjects: 1111

Group type: EXPERIMENTAL
Intervention: USE
Number of subjects: 1111

Group type: EXPERIMENTAL
Intervention: PLAN
Number of subjects: 1111

Group type: COMPARATOR
Intervention: TRACK
Number of subjects: 1111
Study: 33129630

Group type: EXPERIMENTAL
Intervention: Nurse-led program based on Pender's Health Promotion Model
Number of subjects: 62

Group type: COMPARATOR
Intervention: Routine follow-ups (control group)
Number of subjects: 62
Study: 35333028

Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT) intervention, 14 minutes per week for ten weeks
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 36
Study: 33159819

Group type: EXPERIMENTAL
Intervention: HIV infection
Number of subjects: 1128

Group type: EXPERIMENTAL
Intervention: Syphilis infection
Number of subjects: 1128

Group type: EXPERIMENTAL
Intervention: Schistosome infection
Number of subjects: 1128

Group type: EXPERIMENTAL
Intervention: Transactional sex
Number of subjects: 1128

Group type: EXPERIMENTAL
Intervention: Confirmed serological syphilis
Number of subjects: 1128

Group type: EXPERIMENTAL
Intervention: HIV and schistosome infection
Number of subjects: 1128
Study: 34743136

Group type: EXPERIMENTAL
Intervention: Landmark-guided technique
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Nerve stimulation-guided technique
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided technique
Number of subjects: 300

Group type: COMPARATOR
Intervention: All techniques
Number of subjects: 300